Medical Care
Global Oncolytic Virus Therapy Market Research Report 2024
- Jan 20, 24
- ID: 14607
- Pages: 87
- Figures: 167
- Views: 38
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
The global Oncolytic Virus Therapy market was valued at US$ 6 million in 2023 and is anticipated to reach US$ 29 million by 2030, witnessing a CAGR of 24.9% during the forecast period 2024-2030.
Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.
North America and Europe are the main markets, each accounting for about 40% of the market.
This report aims to provide a comprehensive presentation of the global market for Oncolytic Virus Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Virus Therapy.
Report Scope
The Oncolytic Virus Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oncolytic Virus Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncolytic Virus Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys
Segment by Type
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
Segment by Application
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncolytic Virus Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Oncolytic Virus Therapy market was valued at US$ 6 million in 2023 and is anticipated to reach US$ 29 million by 2030, witnessing a CAGR of 24.9% during the forecast period 2024-2030.
Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.
North America and Europe are the main markets, each accounting for about 40% of the market.
This report aims to provide a comprehensive presentation of the global market for Oncolytic Virus Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Virus Therapy.
Report Scope
The Oncolytic Virus Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oncolytic Virus Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncolytic Virus Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys
Segment by Type
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
Segment by Application
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncolytic Virus Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncolytic Virus Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 HSV-based Oncolytic Viruses
1.2.3 Adenoviruses-based Oncolytic Viruses
1.2.4 Vaccinia Virus-based Oncolytic Viruses
1.2.5 Vesicular Stomatitis Virus-based Oncolytic Viruses
1.2.6 Newcastle Disease Virus-based Oncolytic Viruses
1.3 Market by Application
1.3.1 Global Oncolytic Virus Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Melanoma
1.3.3 Prostate Cancer
1.3.4 Breast Cancer
1.3.5 Ovarian Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncolytic Virus Therapy Market Perspective (2019-2030)
2.2 Oncolytic Virus Therapy Growth Trends by Region
2.2.1 Global Oncolytic Virus Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oncolytic Virus Therapy Historic Market Size by Region (2019-2024)
2.2.3 Oncolytic Virus Therapy Forecasted Market Size by Region (2025-2030)
2.3 Oncolytic Virus Therapy Market Dynamics
2.3.1 Oncolytic Virus Therapy Industry Trends
2.3.2 Oncolytic Virus Therapy Market Drivers
2.3.3 Oncolytic Virus Therapy Market Challenges
2.3.4 Oncolytic Virus Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncolytic Virus Therapy Players by Revenue
3.1.1 Global Top Oncolytic Virus Therapy Players by Revenue (2019-2024)
3.1.2 Global Oncolytic Virus Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncolytic Virus Therapy Revenue
3.4 Global Oncolytic Virus Therapy Market Concentration Ratio
3.4.1 Global Oncolytic Virus Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Therapy Revenue in 2023
3.5 Oncolytic Virus Therapy Key Players Head office and Area Served
3.6 Key Players Oncolytic Virus Therapy Product Solution and Service
3.7 Date of Enter into Oncolytic Virus Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncolytic Virus Therapy Breakdown Data by Type
4.1 Global Oncolytic Virus Therapy Historic Market Size by Type (2019-2024)
4.2 Global Oncolytic Virus Therapy Forecasted Market Size by Type (2025-2030)
5 Oncolytic Virus Therapy Breakdown Data by Application
5.1 Global Oncolytic Virus Therapy Historic Market Size by Application (2019-2024)
5.2 Global Oncolytic Virus Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oncolytic Virus Therapy Market Size (2019-2030)
6.2 North America Oncolytic Virus Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oncolytic Virus Therapy Market Size by Country (2019-2024)
6.4 North America Oncolytic Virus Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncolytic Virus Therapy Market Size (2019-2030)
7.2 Europe Oncolytic Virus Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oncolytic Virus Therapy Market Size by Country (2019-2024)
7.4 Europe Oncolytic Virus Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Virus Therapy Market Size (2019-2030)
8.2 Asia-Pacific Oncolytic Virus Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncolytic Virus Therapy Market Size (2019-2030)
9.2 Latin America Oncolytic Virus Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oncolytic Virus Therapy Market Size by Country (2019-2024)
9.4 Latin America Oncolytic Virus Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncolytic Virus Therapy Market Size (2019-2030)
10.2 Middle East & Africa Oncolytic Virus Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Oncolytic Virus Therapy Introduction
11.1.4 Amgen Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.1.5 Amgen Recent Development
11.2 Oncolytics Biotech
11.2.1 Oncolytics Biotech Company Detail
11.2.2 Oncolytics Biotech Business Overview
11.2.3 Oncolytics Biotech Oncolytic Virus Therapy Introduction
11.2.4 Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.2.5 Oncolytics Biotech Recent Development
11.3 Viralytics
11.3.1 Viralytics Company Detail
11.3.2 Viralytics Business Overview
11.3.3 Viralytics Oncolytic Virus Therapy Introduction
11.3.4 Viralytics Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.3.5 Viralytics Recent Development
11.4 Transgene SA
11.4.1 Transgene SA Company Detail
11.4.2 Transgene SA Business Overview
11.4.3 Transgene SA Oncolytic Virus Therapy Introduction
11.4.4 Transgene SA Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.4.5 Transgene SA Recent Development
11.5 Oncolys BioPharma
11.5.1 Oncolys BioPharma Company Detail
11.5.2 Oncolys BioPharma Business Overview
11.5.3 Oncolys BioPharma Oncolytic Virus Therapy Introduction
11.5.4 Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.5.5 Oncolys BioPharma Recent Development
11.6 Targovax
11.6.1 Targovax Company Detail
11.6.2 Targovax Business Overview
11.6.3 Targovax Oncolytic Virus Therapy Introduction
11.6.4 Targovax Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.6.5 Targovax Recent Development
11.7 PsiOxus Therapeutics
11.7.1 PsiOxus Therapeutics Company Detail
11.7.2 PsiOxus Therapeutics Business Overview
11.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Introduction
11.7.4 PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.7.5 PsiOxus Therapeutics Recent Development
11.8 SillaJen Biotherapeutics
11.8.1 SillaJen Biotherapeutics Company Detail
11.8.2 SillaJen Biotherapeutics Business Overview
11.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Introduction
11.8.4 SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.8.5 SillaJen Biotherapeutics Recent Development
11.9 Sorrento Therapeutics
11.9.1 Sorrento Therapeutics Company Detail
11.9.2 Sorrento Therapeutics Business Overview
11.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Introduction
11.9.4 Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.9.5 Sorrento Therapeutics Recent Development
11.10 Lokon Pharma
11.10.1 Lokon Pharma Company Detail
11.10.2 Lokon Pharma Business Overview
11.10.3 Lokon Pharma Oncolytic Virus Therapy Introduction
11.10.4 Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.10.5 Lokon Pharma Recent Development
11.11 Genelux Corporation
11.11.1 Genelux Corporation Company Detail
11.11.2 Genelux Corporation Business Overview
11.11.3 Genelux Corporation Oncolytic Virus Therapy Introduction
11.11.4 Genelux Corporation Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.11.5 Genelux Corporation Recent Development
11.12 Vyriad
11.12.1 Vyriad Company Detail
11.12.2 Vyriad Business Overview
11.12.3 Vyriad Oncolytic Virus Therapy Introduction
11.12.4 Vyriad Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.12.5 Vyriad Recent Development
11.13 TILT Biotherapeutics
11.13.1 TILT Biotherapeutics Company Detail
11.13.2 TILT Biotherapeutics Business Overview
11.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Introduction
11.13.4 TILT Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.13.5 TILT Biotherapeutics Recent Development
11.14 Cold Genesys
11.14.1 Cold Genesys Company Detail
11.14.2 Cold Genesys Business Overview
11.14.3 Cold Genesys Oncolytic Virus Therapy Introduction
11.14.4 Cold Genesys Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.14.5 Cold Genesys Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncolytic Virus Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 HSV-based Oncolytic Viruses
1.2.3 Adenoviruses-based Oncolytic Viruses
1.2.4 Vaccinia Virus-based Oncolytic Viruses
1.2.5 Vesicular Stomatitis Virus-based Oncolytic Viruses
1.2.6 Newcastle Disease Virus-based Oncolytic Viruses
1.3 Market by Application
1.3.1 Global Oncolytic Virus Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Melanoma
1.3.3 Prostate Cancer
1.3.4 Breast Cancer
1.3.5 Ovarian Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncolytic Virus Therapy Market Perspective (2019-2030)
2.2 Oncolytic Virus Therapy Growth Trends by Region
2.2.1 Global Oncolytic Virus Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oncolytic Virus Therapy Historic Market Size by Region (2019-2024)
2.2.3 Oncolytic Virus Therapy Forecasted Market Size by Region (2025-2030)
2.3 Oncolytic Virus Therapy Market Dynamics
2.3.1 Oncolytic Virus Therapy Industry Trends
2.3.2 Oncolytic Virus Therapy Market Drivers
2.3.3 Oncolytic Virus Therapy Market Challenges
2.3.4 Oncolytic Virus Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncolytic Virus Therapy Players by Revenue
3.1.1 Global Top Oncolytic Virus Therapy Players by Revenue (2019-2024)
3.1.2 Global Oncolytic Virus Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncolytic Virus Therapy Revenue
3.4 Global Oncolytic Virus Therapy Market Concentration Ratio
3.4.1 Global Oncolytic Virus Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Therapy Revenue in 2023
3.5 Oncolytic Virus Therapy Key Players Head office and Area Served
3.6 Key Players Oncolytic Virus Therapy Product Solution and Service
3.7 Date of Enter into Oncolytic Virus Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncolytic Virus Therapy Breakdown Data by Type
4.1 Global Oncolytic Virus Therapy Historic Market Size by Type (2019-2024)
4.2 Global Oncolytic Virus Therapy Forecasted Market Size by Type (2025-2030)
5 Oncolytic Virus Therapy Breakdown Data by Application
5.1 Global Oncolytic Virus Therapy Historic Market Size by Application (2019-2024)
5.2 Global Oncolytic Virus Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oncolytic Virus Therapy Market Size (2019-2030)
6.2 North America Oncolytic Virus Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oncolytic Virus Therapy Market Size by Country (2019-2024)
6.4 North America Oncolytic Virus Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncolytic Virus Therapy Market Size (2019-2030)
7.2 Europe Oncolytic Virus Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oncolytic Virus Therapy Market Size by Country (2019-2024)
7.4 Europe Oncolytic Virus Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Virus Therapy Market Size (2019-2030)
8.2 Asia-Pacific Oncolytic Virus Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncolytic Virus Therapy Market Size (2019-2030)
9.2 Latin America Oncolytic Virus Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oncolytic Virus Therapy Market Size by Country (2019-2024)
9.4 Latin America Oncolytic Virus Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncolytic Virus Therapy Market Size (2019-2030)
10.2 Middle East & Africa Oncolytic Virus Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Oncolytic Virus Therapy Introduction
11.1.4 Amgen Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.1.5 Amgen Recent Development
11.2 Oncolytics Biotech
11.2.1 Oncolytics Biotech Company Detail
11.2.2 Oncolytics Biotech Business Overview
11.2.3 Oncolytics Biotech Oncolytic Virus Therapy Introduction
11.2.4 Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.2.5 Oncolytics Biotech Recent Development
11.3 Viralytics
11.3.1 Viralytics Company Detail
11.3.2 Viralytics Business Overview
11.3.3 Viralytics Oncolytic Virus Therapy Introduction
11.3.4 Viralytics Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.3.5 Viralytics Recent Development
11.4 Transgene SA
11.4.1 Transgene SA Company Detail
11.4.2 Transgene SA Business Overview
11.4.3 Transgene SA Oncolytic Virus Therapy Introduction
11.4.4 Transgene SA Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.4.5 Transgene SA Recent Development
11.5 Oncolys BioPharma
11.5.1 Oncolys BioPharma Company Detail
11.5.2 Oncolys BioPharma Business Overview
11.5.3 Oncolys BioPharma Oncolytic Virus Therapy Introduction
11.5.4 Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.5.5 Oncolys BioPharma Recent Development
11.6 Targovax
11.6.1 Targovax Company Detail
11.6.2 Targovax Business Overview
11.6.3 Targovax Oncolytic Virus Therapy Introduction
11.6.4 Targovax Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.6.5 Targovax Recent Development
11.7 PsiOxus Therapeutics
11.7.1 PsiOxus Therapeutics Company Detail
11.7.2 PsiOxus Therapeutics Business Overview
11.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Introduction
11.7.4 PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.7.5 PsiOxus Therapeutics Recent Development
11.8 SillaJen Biotherapeutics
11.8.1 SillaJen Biotherapeutics Company Detail
11.8.2 SillaJen Biotherapeutics Business Overview
11.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Introduction
11.8.4 SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.8.5 SillaJen Biotherapeutics Recent Development
11.9 Sorrento Therapeutics
11.9.1 Sorrento Therapeutics Company Detail
11.9.2 Sorrento Therapeutics Business Overview
11.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Introduction
11.9.4 Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.9.5 Sorrento Therapeutics Recent Development
11.10 Lokon Pharma
11.10.1 Lokon Pharma Company Detail
11.10.2 Lokon Pharma Business Overview
11.10.3 Lokon Pharma Oncolytic Virus Therapy Introduction
11.10.4 Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.10.5 Lokon Pharma Recent Development
11.11 Genelux Corporation
11.11.1 Genelux Corporation Company Detail
11.11.2 Genelux Corporation Business Overview
11.11.3 Genelux Corporation Oncolytic Virus Therapy Introduction
11.11.4 Genelux Corporation Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.11.5 Genelux Corporation Recent Development
11.12 Vyriad
11.12.1 Vyriad Company Detail
11.12.2 Vyriad Business Overview
11.12.3 Vyriad Oncolytic Virus Therapy Introduction
11.12.4 Vyriad Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.12.5 Vyriad Recent Development
11.13 TILT Biotherapeutics
11.13.1 TILT Biotherapeutics Company Detail
11.13.2 TILT Biotherapeutics Business Overview
11.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Introduction
11.13.4 TILT Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.13.5 TILT Biotherapeutics Recent Development
11.14 Cold Genesys
11.14.1 Cold Genesys Company Detail
11.14.2 Cold Genesys Business Overview
11.14.3 Cold Genesys Oncolytic Virus Therapy Introduction
11.14.4 Cold Genesys Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.14.5 Cold Genesys Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Oncolytic Virus Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of HSV-based Oncolytic Viruses
Table 3. Key Players of Adenoviruses-based Oncolytic Viruses
Table 4. Key Players of Vaccinia Virus-based Oncolytic Viruses
Table 5. Key Players of Vesicular Stomatitis Virus-based Oncolytic Viruses
Table 6. Key Players of Newcastle Disease Virus-based Oncolytic Viruses
Table 7. Global Oncolytic Virus Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Oncolytic Virus Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Oncolytic Virus Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Oncolytic Virus Therapy Market Share by Region (2019-2024)
Table 11. Global Oncolytic Virus Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Oncolytic Virus Therapy Market Share by Region (2025-2030)
Table 13. Oncolytic Virus Therapy Market Trends
Table 14. Oncolytic Virus Therapy Market Drivers
Table 15. Oncolytic Virus Therapy Market Challenges
Table 16. Oncolytic Virus Therapy Market Restraints
Table 17. Global Oncolytic Virus Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Oncolytic Virus Therapy Market Share by Players (2019-2024)
Table 19. Global Top Oncolytic Virus Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Therapy as of 2023)
Table 20. Ranking of Global Top Oncolytic Virus Therapy Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Oncolytic Virus Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Oncolytic Virus Therapy Product Solution and Service
Table 24. Date of Enter into Oncolytic Virus Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oncolytic Virus Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Oncolytic Virus Therapy Revenue Market Share by Type (2019-2024)
Table 28. Global Oncolytic Virus Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Oncolytic Virus Therapy Revenue Market Share by Type (2025-2030)
Table 30. Global Oncolytic Virus Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Oncolytic Virus Therapy Revenue Market Share by Application (2019-2024)
Table 32. Global Oncolytic Virus Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Oncolytic Virus Therapy Revenue Market Share by Application (2025-2030)
Table 34. North America Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Oncolytic Virus Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Oncolytic Virus Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Oncolytic Virus Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Oncolytic Virus Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Oncolytic Virus Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Oncolytic Virus Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Oncolytic Virus Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 49. Amgen Company Detail
Table 50. Amgen Business Overview
Table 51. Amgen Oncolytic Virus Therapy Product
Table 52. Amgen Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 53. Amgen Recent Development
Table 54. Oncolytics Biotech Company Detail
Table 55. Oncolytics Biotech Business Overview
Table 56. Oncolytics Biotech Oncolytic Virus Therapy Product
Table 57. Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 58. Oncolytics Biotech Recent Development
Table 59. Viralytics Company Detail
Table 60. Viralytics Business Overview
Table 61. Viralytics Oncolytic Virus Therapy Product
Table 62. Viralytics Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 63. Viralytics Recent Development
Table 64. Transgene SA Company Detail
Table 65. Transgene SA Business Overview
Table 66. Transgene SA Oncolytic Virus Therapy Product
Table 67. Transgene SA Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 68. Transgene SA Recent Development
Table 69. Oncolys BioPharma Company Detail
Table 70. Oncolys BioPharma Business Overview
Table 71. Oncolys BioPharma Oncolytic Virus Therapy Product
Table 72. Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 73. Oncolys BioPharma Recent Development
Table 74. Targovax Company Detail
Table 75. Targovax Business Overview
Table 76. Targovax Oncolytic Virus Therapy Product
Table 77. Targovax Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 78. Targovax Recent Development
Table 79. PsiOxus Therapeutics Company Detail
Table 80. PsiOxus Therapeutics Business Overview
Table 81. PsiOxus Therapeutics Oncolytic Virus Therapy Product
Table 82. PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 83. PsiOxus Therapeutics Recent Development
Table 84. SillaJen Biotherapeutics Company Detail
Table 85. SillaJen Biotherapeutics Business Overview
Table 86. SillaJen Biotherapeutics Oncolytic Virus Therapy Product
Table 87. SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 88. SillaJen Biotherapeutics Recent Development
Table 89. Sorrento Therapeutics Company Detail
Table 90. Sorrento Therapeutics Business Overview
Table 91. Sorrento Therapeutics Oncolytic Virus Therapy Product
Table 92. Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 93. Sorrento Therapeutics Recent Development
Table 94. Lokon Pharma Company Detail
Table 95. Lokon Pharma Business Overview
Table 96. Lokon Pharma Oncolytic Virus Therapy Product
Table 97. Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 98. Lokon Pharma Recent Development
Table 99. Genelux Corporation Company Detail
Table 100. Genelux Corporation Business Overview
Table 101. Genelux Corporation Oncolytic Virus Therapy Product
Table 102. Genelux Corporation Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 103. Genelux Corporation Recent Development
Table 104. Vyriad Company Detail
Table 105. Vyriad Business Overview
Table 106. Vyriad Oncolytic Virus Therapy Product
Table 107. Vyriad Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 108. Vyriad Recent Development
Table 109. TILT Biotherapeutics Company Detail
Table 110. TILT Biotherapeutics Business Overview
Table 111. TILT Biotherapeutics Oncolytic Virus Therapy Product
Table 112. TILT Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 113. TILT Biotherapeutics Recent Development
Table 114. Cold Genesys Company Detail
Table 115. Cold Genesys Business Overview
Table 116. Cold Genesys Oncolytic Virus Therapy Product
Table 117. Cold Genesys Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 118. Cold Genesys Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncolytic Virus Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Oncolytic Virus Therapy Market Share by Type: 2023 VS 2030
Figure 3. HSV-based Oncolytic Viruses Features
Figure 4. Adenoviruses-based Oncolytic Viruses Features
Figure 5. Vaccinia Virus-based Oncolytic Viruses Features
Figure 6. Vesicular Stomatitis Virus-based Oncolytic Viruses Features
Figure 7. Newcastle Disease Virus-based Oncolytic Viruses Features
Figure 8. Global Oncolytic Virus Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Oncolytic Virus Therapy Market Share by Application: 2023 VS 2030
Figure 10. Melanoma Case Studies
Figure 11. Prostate Cancer Case Studies
Figure 12. Breast Cancer Case Studies
Figure 13. Ovarian Cancer Case Studies
Figure 14. Others Case Studies
Figure 15. Oncolytic Virus Therapy Report Years Considered
Figure 16. Global Oncolytic Virus Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Oncolytic Virus Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Oncolytic Virus Therapy Market Share by Region: 2023 VS 2030
Figure 19. Global Oncolytic Virus Therapy Market Share by Players in 2023
Figure 20. Global Top Oncolytic Virus Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Therapy as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Oncolytic Virus Therapy Revenue in 2023
Figure 22. North America Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Oncolytic Virus Therapy Market Share by Country (2019-2030)
Figure 24. United States Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Oncolytic Virus Therapy Market Share by Country (2019-2030)
Figure 28. Germany Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Oncolytic Virus Therapy Market Share by Region (2019-2030)
Figure 36. China Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Oncolytic Virus Therapy Market Share by Country (2019-2030)
Figure 44. Mexico Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Oncolytic Virus Therapy Market Share by Country (2019-2030)
Figure 48. Turkey Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Amgen Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 51. Oncolytics Biotech Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 52. Viralytics Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 53. Transgene SA Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 54. Oncolys BioPharma Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 55. Targovax Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 56. PsiOxus Therapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 57. SillaJen Biotherapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 58. Sorrento Therapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 59. Lokon Pharma Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 60. Genelux Corporation Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 61. Vyriad Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 62. TILT Biotherapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 63. Cold Genesys Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Oncolytic Virus Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of HSV-based Oncolytic Viruses
Table 3. Key Players of Adenoviruses-based Oncolytic Viruses
Table 4. Key Players of Vaccinia Virus-based Oncolytic Viruses
Table 5. Key Players of Vesicular Stomatitis Virus-based Oncolytic Viruses
Table 6. Key Players of Newcastle Disease Virus-based Oncolytic Viruses
Table 7. Global Oncolytic Virus Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Oncolytic Virus Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Oncolytic Virus Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Oncolytic Virus Therapy Market Share by Region (2019-2024)
Table 11. Global Oncolytic Virus Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Oncolytic Virus Therapy Market Share by Region (2025-2030)
Table 13. Oncolytic Virus Therapy Market Trends
Table 14. Oncolytic Virus Therapy Market Drivers
Table 15. Oncolytic Virus Therapy Market Challenges
Table 16. Oncolytic Virus Therapy Market Restraints
Table 17. Global Oncolytic Virus Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Oncolytic Virus Therapy Market Share by Players (2019-2024)
Table 19. Global Top Oncolytic Virus Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Therapy as of 2023)
Table 20. Ranking of Global Top Oncolytic Virus Therapy Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Oncolytic Virus Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Oncolytic Virus Therapy Product Solution and Service
Table 24. Date of Enter into Oncolytic Virus Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oncolytic Virus Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Oncolytic Virus Therapy Revenue Market Share by Type (2019-2024)
Table 28. Global Oncolytic Virus Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Oncolytic Virus Therapy Revenue Market Share by Type (2025-2030)
Table 30. Global Oncolytic Virus Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Oncolytic Virus Therapy Revenue Market Share by Application (2019-2024)
Table 32. Global Oncolytic Virus Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Oncolytic Virus Therapy Revenue Market Share by Application (2025-2030)
Table 34. North America Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Oncolytic Virus Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Oncolytic Virus Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Oncolytic Virus Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Oncolytic Virus Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Oncolytic Virus Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Oncolytic Virus Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Oncolytic Virus Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 49. Amgen Company Detail
Table 50. Amgen Business Overview
Table 51. Amgen Oncolytic Virus Therapy Product
Table 52. Amgen Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 53. Amgen Recent Development
Table 54. Oncolytics Biotech Company Detail
Table 55. Oncolytics Biotech Business Overview
Table 56. Oncolytics Biotech Oncolytic Virus Therapy Product
Table 57. Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 58. Oncolytics Biotech Recent Development
Table 59. Viralytics Company Detail
Table 60. Viralytics Business Overview
Table 61. Viralytics Oncolytic Virus Therapy Product
Table 62. Viralytics Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 63. Viralytics Recent Development
Table 64. Transgene SA Company Detail
Table 65. Transgene SA Business Overview
Table 66. Transgene SA Oncolytic Virus Therapy Product
Table 67. Transgene SA Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 68. Transgene SA Recent Development
Table 69. Oncolys BioPharma Company Detail
Table 70. Oncolys BioPharma Business Overview
Table 71. Oncolys BioPharma Oncolytic Virus Therapy Product
Table 72. Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 73. Oncolys BioPharma Recent Development
Table 74. Targovax Company Detail
Table 75. Targovax Business Overview
Table 76. Targovax Oncolytic Virus Therapy Product
Table 77. Targovax Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 78. Targovax Recent Development
Table 79. PsiOxus Therapeutics Company Detail
Table 80. PsiOxus Therapeutics Business Overview
Table 81. PsiOxus Therapeutics Oncolytic Virus Therapy Product
Table 82. PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 83. PsiOxus Therapeutics Recent Development
Table 84. SillaJen Biotherapeutics Company Detail
Table 85. SillaJen Biotherapeutics Business Overview
Table 86. SillaJen Biotherapeutics Oncolytic Virus Therapy Product
Table 87. SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 88. SillaJen Biotherapeutics Recent Development
Table 89. Sorrento Therapeutics Company Detail
Table 90. Sorrento Therapeutics Business Overview
Table 91. Sorrento Therapeutics Oncolytic Virus Therapy Product
Table 92. Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 93. Sorrento Therapeutics Recent Development
Table 94. Lokon Pharma Company Detail
Table 95. Lokon Pharma Business Overview
Table 96. Lokon Pharma Oncolytic Virus Therapy Product
Table 97. Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 98. Lokon Pharma Recent Development
Table 99. Genelux Corporation Company Detail
Table 100. Genelux Corporation Business Overview
Table 101. Genelux Corporation Oncolytic Virus Therapy Product
Table 102. Genelux Corporation Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 103. Genelux Corporation Recent Development
Table 104. Vyriad Company Detail
Table 105. Vyriad Business Overview
Table 106. Vyriad Oncolytic Virus Therapy Product
Table 107. Vyriad Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 108. Vyriad Recent Development
Table 109. TILT Biotherapeutics Company Detail
Table 110. TILT Biotherapeutics Business Overview
Table 111. TILT Biotherapeutics Oncolytic Virus Therapy Product
Table 112. TILT Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 113. TILT Biotherapeutics Recent Development
Table 114. Cold Genesys Company Detail
Table 115. Cold Genesys Business Overview
Table 116. Cold Genesys Oncolytic Virus Therapy Product
Table 117. Cold Genesys Revenue in Oncolytic Virus Therapy Business (2019-2024) & (US$ Million)
Table 118. Cold Genesys Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncolytic Virus Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Oncolytic Virus Therapy Market Share by Type: 2023 VS 2030
Figure 3. HSV-based Oncolytic Viruses Features
Figure 4. Adenoviruses-based Oncolytic Viruses Features
Figure 5. Vaccinia Virus-based Oncolytic Viruses Features
Figure 6. Vesicular Stomatitis Virus-based Oncolytic Viruses Features
Figure 7. Newcastle Disease Virus-based Oncolytic Viruses Features
Figure 8. Global Oncolytic Virus Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Oncolytic Virus Therapy Market Share by Application: 2023 VS 2030
Figure 10. Melanoma Case Studies
Figure 11. Prostate Cancer Case Studies
Figure 12. Breast Cancer Case Studies
Figure 13. Ovarian Cancer Case Studies
Figure 14. Others Case Studies
Figure 15. Oncolytic Virus Therapy Report Years Considered
Figure 16. Global Oncolytic Virus Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Oncolytic Virus Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Oncolytic Virus Therapy Market Share by Region: 2023 VS 2030
Figure 19. Global Oncolytic Virus Therapy Market Share by Players in 2023
Figure 20. Global Top Oncolytic Virus Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Therapy as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Oncolytic Virus Therapy Revenue in 2023
Figure 22. North America Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Oncolytic Virus Therapy Market Share by Country (2019-2030)
Figure 24. United States Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Oncolytic Virus Therapy Market Share by Country (2019-2030)
Figure 28. Germany Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Oncolytic Virus Therapy Market Share by Region (2019-2030)
Figure 36. China Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Oncolytic Virus Therapy Market Share by Country (2019-2030)
Figure 44. Mexico Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Oncolytic Virus Therapy Market Share by Country (2019-2030)
Figure 48. Turkey Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Oncolytic Virus Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Amgen Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 51. Oncolytics Biotech Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 52. Viralytics Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 53. Transgene SA Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 54. Oncolys BioPharma Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 55. Targovax Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 56. PsiOxus Therapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 57. SillaJen Biotherapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 58. Sorrento Therapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 59. Lokon Pharma Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 60. Genelux Corporation Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 61. Vyriad Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 62. TILT Biotherapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 63. Cold Genesys Revenue Growth Rate in Oncolytic Virus Therapy Business (2019-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232